Organoidsciences Company Description

Organoidsciences Ltd. develops regenerative therapies in South Korea.

It develops ATORM, an adult tissue derived organoid based regenerative medicine platform for the treatment of intractable intestinal ulcers, as well as salivary glands, liver, and uterus disease areas; ODISEI solutions, an organoid-based discovery platform for screening evaluation and identification; and EXPANSION, an organoid-based advanced science for innovative solutions.

The company was founded in 2018 and is based in Seongnam-si, South Korea.

Organoidsciences Ltd.

Country	South Korea
Founded	2018
Industry	Pharmaceutical Preparations
CEO	Jong-Man Yoo

Contact Details

Address: 338 Pangyo-ro Seongnam-si, 13488 South Korea
Phone	82 2 707 2024
Website	organoidrx.com

Stock Details

Ticker Symbol	476040
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2834

Key Executives

Name	Position
Jong-Man Yoo	Chief Executive Officer
Jinman Hong	Chief Financial Officer